Avalon Globocare Corp
ALBT2.260USD
+0.100+4.63%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
3.73MCap. mercado
PérdidaP/E TTM
Más Datos de Avalon Globocare Corp Compañía
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
Información de la empresa
Símbolo de cotizaciónALBT
Nombre de la empresaAvalon Globocare Corp
Fecha de salida a bolsaFeb 22, 2016
Director ejecutivoDr. David Jin, M.D., Ph.D.
Número de empleados5
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 22
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ Capital Market Consolidated
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónALBT
Fecha de salida a bolsaFeb 22, 2016
Director ejecutivoDr. David Jin, M.D., Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Company Secretary
Chief Operating Officer, Company Secretary
34.33K
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Company Secretary
Chief Operating Officer, Company Secretary
34.33K
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Lu (Wenzhao)
6.89%
Jin (David)
2.97%
Vision Capital NY, Inc.
2.88%
Li (Meng)
0.99%
Equitable Holdings, Inc.
0.41%
Other
85.86%
Accionistas
Accionistas
Proporción
Lu (Wenzhao)
6.89%
Jin (David)
2.97%
Vision Capital NY, Inc.
2.88%
Li (Meng)
0.99%
Equitable Holdings, Inc.
0.41%
Other
85.86%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
12.77%
Corporation
3.38%
Investment Advisor
0.57%
Other
83.27%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
37
494.33K
14.25%
+85.00K
2025Q1
39
494.33K
24.18%
+84.18K
2024Q4
39
426.83K
39.01%
+28.37K
2024Q3
38
465.14K
44.22%
+32.28K
2024Q2
37
431.58K
58.50%
+7.86K
2024Q1
35
421.26K
56.90%
-5.41K
2023Q4
36
425.06K
58.60%
-685.00
2023Q3
43
423.55K
58.41%
-5.26K
2023Q2
52
423.10K
61.82%
-6.80K
2023Q1
75
458.47K
67.74%
-1.02K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Lu (Wenzhao)
238.93K
11.69%
+9.00
+0.00%
Mar 31, 2025
Jin (David)
103.00K
5.04%
--
--
Mar 31, 2025
Vision Capital NY, Inc.
100.00K
4.89%
+100.00K
--
Mar 31, 2025
Li (Meng)
34.33K
1.68%
+1.00
+0.00%
Mar 31, 2025
Equitable Holdings, Inc.
14.22K
0.7%
+14.22K
--
Mar 31, 2025
UBS Financial Services, Inc.
2.56K
0.13%
-3.12K
-54.92%
Mar 31, 2025
Tauzin (Wilbert J II)
1.04K
0.05%
+1.04K
--
Mar 31, 2025
Northern Trust Investments, Inc.
121.00
0.01%
+121.00
--
Dec 31, 2023
BofA Global Research (US)
106.00
0.01%
+100.00
+1666.67%
Mar 31, 2025
SBI Securities Co., Ltd.
7.00
0%
-101.00
-93.52%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Oct 24, 2024
Merger
15<1
Oct 24, 2024
Merger
15<1
Oct 24, 2024
Merger
15<1
Oct 24, 2024
Merger
15<1
Jan 04, 2023
Merger
10<1
Jan 04, 2023
Merger
10<1
Fecha
Tipo
Relación
Oct 24, 2024
Merger
15<1
Oct 24, 2024
Merger
15<1
Oct 24, 2024
Merger
15<1
Oct 24, 2024
Merger
15<1
Jan 04, 2023
Merger
10<1
Jan 04, 2023
Merger
10<1
Jan 04, 2023
Merger
10<1
Jan 04, 2023
Merger
10<1
